← Open Payments lookup

FLORENCE NWOKOYE: Open Payments

NPI 1447878863 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,959 in 182 payments from 13 companies in 2025. Trend: 2023 $1,925 · 2024 $2,456 · 2025 $2,959

Food & beverage: $2,959
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.37$548
Janssen Pharmaceuticals, Inc16$512
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)33$508
Neurocrine BioSciences, Inc.17$500
Supernus Pharmaceuticals, Inc.42$291
Teva Pharmaceuticals USA, Inc.19$234
Lundbeck LLC5$107
Otsuka America Pharmaceutical, Inc.4$86
Takeda Pharmaceuticals U.S.A., Inc.3$61
Luye Pharma (USA) Ltd.2$40

Products named: COBENFY, INVEGA SUSTENNA, CAPLYTA, INGREZZA, Qelbree, AUSTEDO XR, REXULTI, TRINTELLIX.

Industry payments across TX — which companies pay providers there.